Draig Therapeutics
Cardiff, GB · 44 employees on LinkedIn · 9 known investors
Find your way into Draig Therapeutics
287 people in our graph share verified history with the Draig Therapeutics team — schools, employers, funds. One of them is your warm intro.
Draig develops neuropsychiatric therapies targeting glutamate and GABA pathways through AMPA and GABAA receptor modulators, serving patients with neuropsychiatric disorders. The company was founded by Cardiff University and SV Health Investors in 2024.
Founders & leadership

Investors · 9
Also in the syndicate · 2
Funding
SEC filings, press & company announcements$65M disclosed across 1 round · 2026
- $65MSeries BJul 2026 · 2 sources
Deep Track Capital (lead), British Business Bank, Janus Henderson Investors, Jefferson Life Sciences, Marshall Wace
Source ↗
Source: company announcements and press reports — follow each round's link for the claim.
Companies House · registry record
View on Companies House ↗- Registered name
- DRAIG THERAPEUTICS LTD
- Company number
- 13405365
- Status
- Active
- Company type
- Private limited company
- Incorporated
- 18 May 2021
- Registered office
- Sbarc Spark, Maindy Road, Cardiff, CF24 4HQ
- Nature of business (SIC)
- 72110 — Research and experimental development on biotechnology
- Accounts
- last made up to 31 Dec 2025 · next due 30 Sept 2027
- Confirmation statement
- last made up to 17 May 2026 · next due 31 May 2027
Current officers · 9
- Samantha Louise Budd Haeberlein — director, appointed 5 Sept 2024
- Colleen Cuffaro — director, appointed 10 Jun 2025
- Charles Montfort Dunn — director, appointed 5 Sept 2024
- Ivana Magovcevic-Liebisch — director, appointed 10 Nov 2025
- Ruth Mitchell Mckernan — director, appointed 5 Sept 2024
- Jodie Pope Morrison — director, appointed 17 Mar 2026
- Liam Ratcliffe — director, appointed 10 Jun 2025
- Laetitia Schwab — director, appointed 10 Jun 2025
- Douglas Edward Williams — director, appointed 10 Jul 2025
Source: Companies House public register · retrieved 6 Sept 2026. Contains public sector information licensed under the Open Government Licence v3.0.
In the news
Fierce Biotech Fundraising Tracker '26: InduPro assembles $77M; Vaderis nets $152M series Bfiercebiotech.com · Aug 2026Frequently asked questions
- What does Draig Therapeutics do?
- Draig develops neuropsychiatric therapies targeting glutamate and GABA pathways through AMPA and GABAA receptor modulators, serving patients with neuropsychiatric disorders. The company was founded by Cardiff University and SV Health Investors in 2024.
- Who founded Draig Therapeutics?
- Draig Therapeutics was founded by John Atack, Simon Ward.
- Who are Draig Therapeutics's investors?
- Draig Therapeutics's investors include Access Biotechnology, Canaan Partners, Sanofi Ventures, SV Health Investors, SR One Capital Management, British Business Bank, Janus Henderson Investors.
- How much funding has Draig Therapeutics raised?
- Draig Therapeutics has disclosed $65M raised across 1 round.
- Where is Draig Therapeutics headquartered?
- Draig Therapeutics is headquartered in Cardiff, GB.


